This topic contains a solution. Click here to go to the answer

Author Question: Utilizing the Chevron framework, how did the Court respond to the first question of whether Congress ... (Read 24 times)

dmcintosh

  • Hero Member
  • *****
  • Posts: 517
Utilizing the Chevron framework, how did the Court respond to the first question of whether Congress has directly addressed the precise question at issue?

Question 2

May the National Labor Relations Board obtain injunctive relief against unions in light of the Federal Anti-Injunction Act?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

fraziera112

  • Sr. Member
  • ****
  • Posts: 356
Answer to Question 1

The Court determined that Congress had not addressed the precise question at issue. The statute does not define student or otherwise attend to the question whether medical residents are subject to FICA.

Answer to Question 2

Section 10(1) of the NLRA allows the NLRB to seek appropriate relief against unions in certain matters such as secondary boycotts and jurisdictional disputes. This section of the NLRA thus narrowed the application of the Federal Anti-Injunction Act. In Chapter 7 Boys Market injunctions will be discussed, where, under limited circumstances, a court may enjoin a strike in violation of a contractual no-strike clause.




dmcintosh

  • Member
  • Posts: 517
Reply 2 on: Jun 24, 2018
Excellent


carlsona147

  • Member
  • Posts: 341
Reply 3 on: Yesterday
Gracias!

 

Did you know?

There are over 65,000 known species of protozoa. About 10,000 species are parasitic.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library